4//SEC Filing
VENROCK ENTERPRENEURS FUND LP 4
Accession 0001239244-04-000003
CIK 0001062216other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 3:48 PM ET
Size
7.5 KB
Accession
0001239244-04-000003
Insider Transaction Report
Form 4
VENROCK ENTERPRENEURS FUND LP
10% Owner
Transactions
- Conversion
Series C Convertible Preferred Stock
2004-04-08−40,000→ 0 total→ Common Stock (14,233 underlying) - Conversion
Common Stock
2004-04-08+14,233→ 14,233 total
Footnotes (3)
- [F1]The shares of each Series of Preferred Stock were convertible into the number of shares of Common Stock indicated, and upon the closing of the Issuer's initial public offering of Common Stock, all such shares of Preferred Stock were automatically converted into the number of shares of Common Stock indicated.
- [F2]Upon the closing of the Issuer's initial public offering, each share of Series C Convertible Preferred Stock automatically converted into 0.3559 shares of the Issuer's Common Stock.
- [F3]Not applicable.
Documents
Issuer
MEMORY PHARMACEUTICALS CORP
CIK 0001062216
Entity typeother
Related Parties
1- filerCIK 0001239244
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 3:48 PM ET
- Size
- 7.5 KB